Terumo Europe NV Press releases

June 6th, 2008:
World Wide Development and Distribution agreement for an Automated Whole Blood or Blood Component Processing system.

April 28th, 2008:
Japanese Global Medical Technology Company Opens Office in Switzerland.

February 15th, 2008:
Terumo Announces First CE Certified NOBORI™ DES in Use.

January 18th, 2008:
Terumo receives CE Certificate for NOBORI™ DRUG-ELUTING STENT.

October 23rd, 2007:
Terumo’s NOBORI™ Drug Eluting Stent System continues to show exellent results.

October 27th, 2006:
Terumo Europe N.V. (Belgium) opens Representative Office in Moscow.

April 27th, 2006:
Terumo and Biocompatibles establish European marketing partnership for Drug Eluting Bead products.

February 28th, 2006:
Terumo Announces Acquisition of MicroVention.

May 26th, 2005:
Terumo Europe N.V. enrols First Patient in Clinical Trial of the Nobori™ Drug-eluting Coronary Stent.

March 31st, 2005:
Introduction of DC BEAD™ on Key European Markets.

December 17th, 2004:
Terumo Announces Initiation of NOBORI 1 Clinical Trial.

December 15th, 2004:
Terumo Initiates Vulnerable Plaque Program with Exclusive License from Massachusetts General Hospital.

January 19th, 2004:
Terumo Heart, Inc. Announces the World's First Implant of the DuraHeart LVAS.

October 28th, 2003:
Biosensors and Terumo Sign Licensing Agreement on First Drug-Eluting Stent to Undergo Full Clinical Trials in Japan.

October 23rd, 2003:
Global Distribution Agreement with TERUMO for Bead Block™ is announced by Biocompatibles International PLC.